Revance Therapeutics (RVNC)
(Real Time Quote from BATS)
$3.89 USD
+0.13 (3.46%)
Updated Jul 26, 2024 09:44 AM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.48 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | 18.18% |
ABR | 1.70 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.83 |
Next Year | -0.74 |
EPS (TTM) | -2.70 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 66.12M | 70.07M | 275.60M | 380.11M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 69.00M | 75.00M | 284.40M | 416.44M |
Low Estimate | 61.95M | 65.08M | 267.76M | 356.76M |
Year ago Sales | 58.13M | 56.78M | 234.04M | 275.60M |
Year over Year Growth Est. | 13.74% | 23.40% | 17.76% | 37.92% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.48 | -0.41 | -1.83 | -0.74 |
# of Estimates | 2 | 2 | 1 | 2 |
Most Recent Consensus | -0.48 | -0.41 | -1.83 | -0.74 |
High Estimate | -0.48 | -0.39 | -1.83 | -0.58 |
Low Estimate | -0.48 | -0.43 | -1.83 | -0.89 |
Year ago EPS | -0.80 | -0.74 | -3.83 | -1.83 |
Year over Year Growth Est. | 40.00% | 44.59% | 52.22% | 59.84% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.48 | -0.41 | -1.83 | -0.74 |
7 Days Ago | -0.48 | -0.41 | -1.83 | -0.74 |
30 Days Ago | -0.48 | -0.41 | -1.83 | -0.74 |
60 Days Ago | -0.48 | -0.41 | -1.83 | -0.74 |
90 Days Ago | -0.56 | -0.52 | -2.18 | -1.13 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.48 | -0.41 | -1.83 | -0.74 |
Zacks Consensus Estimate | -0.48 | -0.41 | -1.83 | -0.74 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | -0.62 | -0.74 | -0.80 | NA |
Estimate | -0.66 | -0.79 | -1.02 | -0.72 | NA |
Difference | 0.12 | 0.17 | 0.28 | -0.08 | 0.12 |
Surprise | 18.18% | 21.52% | 27.45% | -11.11% | 14.01% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more